Evidence map›Paper›PMID 36475318›Full record

ArticleJournal of preventive medicine and public health = Yebang Uihakhoe chi2022

Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older.

Youjin Hong, Sangjun Lee, Sungji Moon, Soseul Sung, Woojin Lim, Kyungsik Kim, Seokyung An, Jeoungbin Choi, Kwang-Pil Ko, Inah Kim and 2 more

Abstract read
In one paragraph

Article in Journal of preventive medicine and public health = Yebang Uihakhoe chi, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Youjin HongDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sangjun LeeDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Sungji MoonDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Soseul SungDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Woojin LimDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kyungsik KimDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Seokyung AnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Jeoungbin ChoiDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kwang-Pil KoClinical Preventive Medicine Center, Seoul National University Bundang Hospital, Seoul, Korea.
Inah KimDepartment of Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, Korea.
Jung Eun LeeDepartment of Food and Nutrition, Seoul National University, Seoul, Korea.
Sue K ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.

Funding

Korean Foundation for Cancer Research 2017-A-2Seoul National University Hospital
6 · The paper itself

Abstract

objectivesThis study aimed to identify the current patterns of cancer incidence and estimate the projected cancer incidence and mortality between 2020 and 2035 in Korea.

methodsData on cancer incidence cases were extracted from the Korean Statistical Information Service from 2000 to 2017, and data on cancer-related deaths were extracted from the National Cancer Center from 2000 to 2018. Cancer cases and deaths were classified according to the International Classification of Diseases, 10th edition. For the current patterns of cancer incidence, age-standardized incidence rates (ASIRs) and age-standardized mortality rates were investigated using the 2000 mid-year estimated population aged over 20 years and older. A joinpoint regression model was used to determine the 2020 to 2035 trends in cancer.

resultsOverall, cancer cases were predicted to increase from 265 299 in 2020 to 474 085 in 2035 (growth rate: 1.8%). The greatest increase in the ASIR was projected for prostate cancer among male (7.84 vs. 189.53 per 100 000 people) and breast cancer among female (34.17 vs. 238.45 per 100 000 people) from 2000 to 2035. Overall cancer deaths were projected to increase from 81 717 in 2020 to 95 845 in 2035 (average annual growth rate: 1.2%). Although most cancer mortality rates were projected to decrease, those of breast, pancreatic, and ovarian cancer among female were projected to increase until 2035.

conclusionsThese up-to-date projections of cancer incidence and mortality in the Korean population may be a significant resource for implementing cancer-related regulations or developing cancer treatments.

Indexed as

NeoplasmsAdultFemaleHumansMaleEpidemiologyIncidenceMortalityNeoplasms

Identifiers

PMID36475318
PMCPMC9742400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.